Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 73 publications
Paediatric therapeutic development workshop on osteosarcoma.
Journal: British journal of cancer
Published: April 07, 2026
Considerations for Clinical Trial Design in Relapsed and Refractory Osteosarcoma: An FDA Symposium.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 09, 2025
The Childhood Cancer Data Initiative: Using the Power of Data to Learn From and Improve Outcomes for Every Child and Young Adult With Pediatric Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 02, 2023
Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 24, 2023
A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 29, 2022
New Horizons in the Treatment of Osteosarcoma.
Journal: The New England journal of medicine
Published: November 24, 2021
LRRC15 antibody-drug conjugates show promise as osteosarcoma therapeutics in preclinical studies.
Journal: Pediatric blood & cancer
Published: April 29, 2020
Molecular mechanisms of Guadecitabine induced FGFR4 down regulation in alveolar rhabdomyosarcomas.
Journal: Neoplasia (New York, N.Y.)
Published: February 26, 2020
Results of a Randomized, Double-Blinded, Placebo-Controlled, Phase 2.5 Study of Saracatinib (AZD0530), in Patients with Recurrent Osteosarcoma Localized to the Lung.
Journal: Sarcoma
Published: November 18, 2019
Last Updated: 09/26/2026